Cardiac Risk in the Young Clinical Research Fellow, Cardiology Clinical Academic Group, St George's University of London, London, UK.
Division of Cardiovascular Sciences, The University of Manchester, Manchester, UK.
Clin Cardiol. 2020 Aug;43(8):889-896. doi: 10.1002/clc.23343. Epub 2020 Feb 12.
A greater understanding of the pathogenic mechanisms underpinning hypertrophic cardiomyopathy (HCM) has translated to improved medical care and better survival of affected individuals. Historically these patients were considered to be at high risk of sudden cardiac death (SCD) during exercise; therefore, exercise recommendations were highly conservative and promoted a sedentary life style. There is emerging evidence that suggests that exercise in HCM has a favorable effect on cardiovascular remodeling and moderate exercise programs have not raised any safety concerns. Furthermore, individuals with HCM have a similar burden of atherosclerotic risk factors as the general population in whom exercise has been associated with a reduction in myocardial infarction, stroke, and heart failure, especially among those with a high-risk burden. Small studies revealed that athletes who choose to continue with regular competition do not demonstrate adverse outcomes when compared to those who discontinue sport, and active individuals implanted with an implantable cardioverter defibrillator do not have an increased risk of appropriate shocks or other adverse events. The recently published exercise recommendations from the European Association for Preventative Cardiology account for more contemporary evidence and adopt a more liberal stance regarding competitive and high intensity sport in individuals with low-risk HCM. This review addresses the issue of exercise in individuals with HCM, and explores current evidence supporting safety of exercise in HCM, potential caveats, and areas of further research.
对肥厚型心肌病 (HCM) 发病机制的深入了解,已转化为改善医疗护理水平,并提高了患者的生存机会。历史上,这些患者在运动时被认为存在发生心源性猝死 (SCD) 的高风险;因此,运动建议非常保守,提倡久坐的生活方式。目前有新的证据表明,HCM 患者运动对心血管重塑有积极影响,适度的运动方案不会引起任何安全问题。此外,HCM 患者与一般人群一样,具有类似的动脉粥样硬化危险因素负担,而运动与心肌梗死、中风和心力衰竭的减少有关,尤其是在高风险负担的人群中。小型研究表明,与停止运动的患者相比,选择继续进行常规比赛的运动员没有出现不良结果,而植入植入式心律转复除颤器的活跃个体也没有增加适当电击或其他不良事件的风险。最近发表的欧洲预防心脏病学协会的运动建议考虑了更具现代意义的证据,并对低危 HCM 患者的竞技和高强度运动采取了更为自由的立场。本文探讨了 HCM 患者运动的问题,研究了支持 HCM 患者运动安全性的现有证据、潜在注意事项和进一步研究的领域。